Edition:
United Kingdom

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

6.18USD
21 Sep 2018
Change (% chg)

$-0.27 (-4.19%)
Prev Close
$6.45
Open
$6.45
Day's High
$6.50
Day's Low
$6.18
Volume
14,560
Avg. Vol
5,578
52-wk High
$12.82
52-wk Low
$5.44

Latest Key Developments (Source: Significant Developments)

Alpine Immune Sciences Provides Corporate Update And Reports Full Year 2017 Financial Results
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Alpine Immune Sciences Inc ::ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2017 FINANCIAL RESULTS.ALPINE IMMUNE SCIENCES - EXPECTS TO HAVE CASH TO FUND OPERATIONS INTO 2020, INCLUDING CLINICAL ADVANCEMENT OF ITS LEAD PROGRAMS ALPN-101 AND ALPN-202.  Full Article

Alpine Immune Sciences qtrly earnings per share ‍$0.18​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Alpine Immune Sciences Inc ::Alpine Immune Sciences reports corporate update and third quarter 2017 financial results.Q3 revenue $100,000 versus $700,000.Alpine Immune Sciences Inc - ‍company expects to have cash to fund operations into 2020​.Alpine Immune Sciences Inc qtrly earnings per share ‍$0.18​.  Full Article

BRIEF-Alpine Immune Sciences Appoints Chris Peetz To Its Board

* ALPINE IMMUNE SCIENCES APPOINTS LIFE SCIENCES EXECUTIVE CHRIS PEETZ TO ITS BOARD OF DIRECTORS Source text for Eikon: Further company coverage: